DK161590D0 - PROCEDURE FOR PREPARING A VERY PURE NON-INFECTIOUS ANTIHAEMOPHILIFIC FACTOR BY CHROMATOGRAPHY - Google Patents

PROCEDURE FOR PREPARING A VERY PURE NON-INFECTIOUS ANTIHAEMOPHILIFIC FACTOR BY CHROMATOGRAPHY

Info

Publication number
DK161590D0
DK161590D0 DK161590A DK161590A DK161590D0 DK 161590 D0 DK161590 D0 DK 161590D0 DK 161590 A DK161590 A DK 161590A DK 161590 A DK161590 A DK 161590A DK 161590 D0 DK161590 D0 DK 161590D0
Authority
DK
Denmark
Prior art keywords
factor
infectious
chromatography
antihaemophilific
preparing
Prior art date
Application number
DK161590A
Other languages
Danish (da)
Other versions
DK161590A (en
Inventor
Andrew Smith
Original Assignee
Octapharma Ag
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Family has litigation
First worldwide family litigation filed litigation Critical https://patents.darts-ip.com/?family=8199529&utm_source=***_patent&utm_medium=platform_link&utm_campaign=public_patent_search&patent=DK161590(D0) "Global patent litigation dataset” by Darts-ip is licensed under a Creative Commons Attribution 4.0 International License.
Application filed by Octapharma Ag filed Critical Octapharma Ag
Publication of DK161590D0 publication Critical patent/DK161590D0/en
Publication of DK161590A publication Critical patent/DK161590A/en

Links

Classifications

    • CCHEMISTRY; METALLURGY
    • C07ORGANIC CHEMISTRY
    • C07KPEPTIDES
    • C07K14/00Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof
    • C07K14/435Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from animals; from humans
    • C07K14/745Blood coagulation or fibrinolysis factors
    • C07K14/755Factors VIII, e.g. factor VIII C (AHF), factor VIII Ag (VWF)
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61KPREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K38/00Medicinal preparations containing peptides

Landscapes

  • Health & Medical Sciences (AREA)
  • Chemical & Material Sciences (AREA)
  • Organic Chemistry (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Genetics & Genomics (AREA)
  • Medicinal Chemistry (AREA)
  • Zoology (AREA)
  • Biochemistry (AREA)
  • Biophysics (AREA)
  • General Health & Medical Sciences (AREA)
  • Toxicology (AREA)
  • Gastroenterology & Hepatology (AREA)
  • Molecular Biology (AREA)
  • Proteomics, Peptides & Aminoacids (AREA)
  • Hematology (AREA)
  • Medicines Containing Material From Animals Or Micro-Organisms (AREA)
  • Medicines That Contain Protein Lipid Enzymes And Other Medicines (AREA)
  • Peptides Or Proteins (AREA)
  • Chemical Vapour Deposition (AREA)
  • Intermediate Stations On Conveyors (AREA)

Abstract

A process for producing a high-purity, non-infectious antihaemophilia factor (AHF or factor VIII) from blood plasma by treating a fraction enriched with factor VIII with biocompatible organic solvents/detergents followed by further cleaning steps is characterized in that the fraction enriched with factor VIII is obtained by a chromatographic process. After removal of viruses, said fraction advantageously undergoes further gel permeation chromatography with ion-exchange materials.
DK161590A 1988-11-05 1990-07-04 Device for transverse displacement of rolling pallets DK161590A (en)

Applications Claiming Priority (2)

Application Number Priority Date Filing Date Title
EP88118478A EP0367840B1 (en) 1988-11-05 1988-11-05 Process for producing by chromatography a non-infectious antihemophilic factor with high purity
PCT/EP1989/001247 WO1990005140A1 (en) 1988-11-05 1989-10-19 Process for producing a high-purity, non-infectious antihaemophilia factor by chromatography

Publications (2)

Publication Number Publication Date
DK161590D0 true DK161590D0 (en) 1990-07-04
DK161590A DK161590A (en) 1990-07-04

Family

ID=8199529

Family Applications (1)

Application Number Title Priority Date Filing Date
DK161590A DK161590A (en) 1988-11-05 1990-07-04 Device for transverse displacement of rolling pallets

Country Status (8)

Country Link
EP (1) EP0367840B1 (en)
JP (1) JPH03502200A (en)
AT (1) ATE85221T1 (en)
DE (1) DE3878245D1 (en)
DK (1) DK161590A (en)
ES (1) ES2053684T3 (en)
FI (1) FI903366A0 (en)
WO (1) WO1990005140A1 (en)

Families Citing this family (12)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
DE4008852A1 (en) * 1990-03-20 1991-09-26 Octapharma Ag METHOD FOR PRODUCING NON-INFECTIOUS BLOOD PLASMA
IT1248723B (en) * 1990-06-12 1995-01-26 Scalvo S P A PROCESS FOR THE PURIFICATION OF FACTOR VIII AND FACTOR VIII OBTAINED WITH SUCH PROCESS
FR2681867B1 (en) * 1991-09-26 1993-12-31 Pasteur Merieux Serums Vaccins FACTOR VIII PURIFICATION PROCESS AND PREPARATIONS OBTAINED.
DE4204694C3 (en) * 1992-02-01 1995-10-12 Octapharma Ag Method for obtaining highly pure, virus-inactivated factor VIII by means of anion exchange chromatography
AT399818B (en) * 1992-04-24 1995-07-25 Immuno Ag METHOD FOR PRODUCING A HIGH PURIFIED VIRUS-SAFE FACTOR VIII PREPARATION
IT1256622B (en) * 1992-12-04 1995-12-12 Sclavo Spa PROCESS FOR THE EXTRACTION OF THE FACTOR VIII-FACTOR VON WILLEBRAND (FVIII: C-FVW) FROM TOTAL HUMAN PLASMA.
ES2118386T3 (en) 1993-02-09 1998-09-16 Octapharma Ag PROCEDURE FOR THE INACTIVATION OF VIRUSES THAT ARE NOT PROVIDED WITH LIPID ENVELOPES.
SE9301582D0 (en) * 1993-05-07 1993-05-07 Kabi Pharmacia Ab PURIFICATION OF PLASMA PROTEINS
DE4337573C1 (en) * 1993-11-04 1995-05-18 Octapharma Ag Process for the preparation of a virus-inactivated factor VIII-containing fraction by means of chromatographic methods
AT407159B (en) 1997-06-13 2001-01-25 Immuno Ag METHOD FOR DEPOSITING VIRALS AND MOLECULAR PATHOGENS FROM A BIOLOGICAL MATERIAL
AU5678500A (en) * 1999-06-08 2000-12-28 Octapharma Ag Process for removing viruses from biological samples
EP1148063A1 (en) 2000-04-18 2001-10-24 Octapharma AG Composition containing hemostatic activ vWF and process for its preparation

Family Cites Families (14)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
BE713764A (en) 1967-05-01 1968-09-16 Baxter Travenol Lab
JPS52125609A (en) 1976-04-09 1977-10-21 Green Cross Corp:The Purification of agglutination factor viii
DE2635894A1 (en) * 1976-08-10 1978-02-16 Biotest Serum Institut Gmbh Prepn. of concentrates contg. anti-haemophilic globulin:A - by adsorption onto di:ethylamino-ethyl-cellulose from plasma etc., then elution with buffer
US4386068A (en) * 1980-02-26 1983-05-31 Cutter Laboratories, Inc. Antihemophilic factor concentrate and method for preparation
US4495175A (en) 1982-08-05 1985-01-22 University Of Rochester Preparation of highly purified human antihemophilic factor
US4540573A (en) 1983-07-14 1985-09-10 New York Blood Center, Inc. Undenatured virus-free biologically active protein derivatives
US4478825A (en) * 1983-10-14 1984-10-23 Armour Pharmaceutical Company Warm ethanol method for preparation of low fibrinogen antihemophilic factor
US4508709A (en) * 1983-12-05 1985-04-02 Armour Pharmaceutical Company Process for purifying factor VIII:C
DE3432083A1 (en) 1984-08-31 1986-03-06 Behringwerke Ag, 3550 Marburg PASTEURIZED, ISOAGGLUTININ-FREE FACTOR VIII PREPARATION AND METHOD FOR THE PRODUCTION THEREOF
US4743680A (en) 1985-02-01 1988-05-10 New York University Method for purifying antihemophilic factor
ATE73820T1 (en) * 1986-03-27 1992-04-15 Octapharma Ag PROCESS FOR THE PRODUCTION OF A HIGHLY PURIFIED ANTIHAEMOPHILIA FACTOR.
US4789545A (en) 1986-03-31 1988-12-06 New York Blood Center, Inc. Removal of lipid soluble process chemicals from biological materials by extraction with naturally occurring oils or synthetic substitutes thereof
JPS63108000A (en) * 1986-05-15 1988-05-12 Green Cross Corp:The Purification of factor viii
DE3878227D1 (en) 1988-05-27 1993-03-18 Centre Regional De Transfusion METHOD FOR PRODUCING A HIGHLY PURE, VIRUS-FREE ANTIHAEMOPHILIA ACTUATOR BY CHROMATOGRAPHY.

Also Published As

Publication number Publication date
ATE85221T1 (en) 1993-02-15
EP0367840B1 (en) 1993-02-03
FI903366A0 (en) 1990-07-04
WO1990005140A1 (en) 1990-05-17
DK161590A (en) 1990-07-04
ES2053684T3 (en) 1994-08-01
JPH03502200A (en) 1991-05-23
DE3878245D1 (en) 1993-03-18
EP0367840A1 (en) 1990-05-16

Similar Documents

Publication Publication Date Title
DK161590D0 (en) PROCEDURE FOR PREPARING A VERY PURE NON-INFECTIOUS ANTIHAEMOPHILIFIC FACTOR BY CHROMATOGRAPHY
ATE72121T1 (en) PROCESS FOR THE PRODUCTION OF APOLIPOPROTEINS FROM BLOOD PLASMA OR SERUM FRACTIONS.
DK0852585T3 (en) Method of treating Alzheimer's disease using glial cell-derived neurotrophic factor (GDNF) protein product
PL286746A1 (en) Method of obtaining a complex of antihaemophilic globulin with the willebrand factor from whole blood plasma, in the form of concentrate
DK0509036T3 (en) Optically pure R (-) - albuterol for the treatment of asthma
NO931476D0 (en) PROCEDURE FOR MANUFACTURING A VIRUS SAFE, HIGHLY FACTOR VIII
NO902499D0 (en) PROCEDURE FOR THE PREPARATION OF PURIFIED ALBUMIN SOLUTIONS.
UA27733C2 (en) Blood coagulation factor xi concentrate and process for preparing same
EP0309787A3 (en) Process for producing a highly purified, virus-free and biologically active transferrin preparation
DE59102623D1 (en) METHOD FOR PRODUCING NON-INFECTIOUS BLOOD PLASMA.
DK0764658T3 (en) Process for producing immunoglobulins from fractions generated by fractionation of human blood plasma
ATE112544T1 (en) PROCESS FOR REMOVAL OF VINYLIDE CHLORIDE AND OTHER UNSATURATED COMPOUNDS FROM 1,1-DICHLORO-1-FLUOROETHANE.
ATE85220T1 (en) PROCESS FOR THE PRODUCTION OF A HIGH PURITY, VIRUS-FREE ANTI-HEMOPHILIA FACTOR USING CHROMATOGRAPHY.
DE68904137D1 (en) METHOD FOR PRODUCING 1,1, -DICHLOR-1-FLUOROETHANE.
ATE228533T1 (en) METHOD FOR PRODUCING A FRACTION CONTAINING VIRUS-INACTIVATED FACTOR VIII USING CHROMATOGRAPHIC METHODS
DE69308934D1 (en) Process for the preparation of 1,1,1,2-tetrafluoroethane
HU906946D0 (en) Process for producing pharmaceutical preparative containing n-methyl-2-(3-pyridyl)-tetrahydropyrane-2-carbothioamide-1-oxide applicable for treating insufficiency of coronary arteries
NO168578C (en) PROCEDURE FOR THE PREPARATION OF METHYL-METACRYLATE USING ISOSMOIC ACID
FI872982A (en) VAKUUMRENINGSFOERFARANDE FOER GLASMATERIAL, MED KONTROLLERAD SKUMNING.
IT8983619A0 (en) PROCEDURE AND MEANS OF USING THE COLUMN OF BICYCLE FRAMES, PARTICULARLY COUNTRY, AS THE CYLINDER OF THE BICYCLE SERVICE PUMP AND BICYCLES OBTAINED WITH SUCH PROCESS AND MEANS.

Legal Events

Date Code Title Description
PBP Patent lapsed
AHS Application shelved for other reasons than non-payment